Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors-Reference-Cited by-同舟云学术

Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

Published:1997-04 Issue:4 Volume:25 Page:991-994
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rayyes O A,Wallmark A,Florén C

Publisher

Wiley

Subject

Hepatology

Reference26 articles.

1. Acute myocardial infarction in renal transplant recipients: incidence and prognosis;Gunnarsson;Eur Heart J,1984

2. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone;Uretsky;Circulation,1987

3. Atherosclerosis and lipid disorders after renal transplantation;Drüeke;Kidney Int,1991

4. Effects of cyclosporine on plasma lipoproteins in bone marrow transplantation patients;López-Miranda;Clin Biochem,1992

5. Secondary causes of hyperlipidaemia;Stone;Med Clin North Am,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) for the Monitoring of Treatment Response to Cyclosporine in Patients with Psoriasis;Life;2023-09-06

2. Drugs for the Skinternist;Comprehensive Dermatologic Drug Therapy;2021

3. Drug-Induced Dyslipidemia;Dyslipidemias;2015

4. Drugs for the skinternist;Comprehensive Dermatologic Drug Therapy;2013

5. Cyclosporin A and atherosclerosis — Cellular pathways in atherogenesis;Pharmacology & Therapeutics;2010-10